Proteopedia - User contributions [en]

B-RAF with PLX4032

2010-10-06T13:08:09Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene> 
<scene name='B-RAF_with_PLX4032/Superposition3og71uwh/1'>Superposition</scene> 
<scene name='B-RAF_with_PLX4032/Confirmation_change_dfg-in/1'>Confirmation Change DFG-In</scene> 
<scene name='B-RAF_with_PLX4032/Confirmation_change_dfg-out/1'>Confirmation Change DFG-Out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-10-06T13:06:07Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene> 
<scene name='B-RAF_with_PLX4032/Superposition3og71uwh/1'>Superposition</scene> 
<scene name='B-RAF_with_PLX4032/Confirmation_change_dfg-in/1'>Confirmation Change DFG-In</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-10-06T12:59:05Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene> 
<scene name='B-RAF_with_PLX4032/Superposition3og71uwh/1'>Superposition</scene> 
<scene name='B-RAF_with_PLX4032/Confirmation_change_dfg-in/1'>TextToBeDisplayed</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-10-05T19:06:14Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene> 
<scene name='B-RAF_with_PLX4032/Superposition3og71uwh/1'>Superposition</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-10-05T02:31:26Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='600' color='white' frame='true' align='left' caption='testcaption' />
<applet load='1uwh' size='600' color='white' frame='true' align='right' caption='testcaption' />

B-RAF with PLX4032

2010-10-05T02:31:04Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene>
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='600' color='white' frame='true' align='left' caption='testcaption' />
<applet load='1uwh' size='600' color='white' frame='true' align='right' caption='testcaption' />

B-RAF with PLX4032

2010-10-05T02:29:25Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='600' color='white' frame='true' align='left' caption='testcaption' />
<scene name='B-RAF_with_PLX4032/Atp/1'>TextToBeDisplayed</scene>
<applet load='1uwh' size='600' color='white' frame='true' align='right' caption='testcaption' />

Sandbox 85

2010-10-05T02:11:05Z

J.D. Woodruff:

<table style="background-color:#ffffc0" cellpadding="8" width="95%" border="0"><tr><td>Please do NOT make changes to this Sandbox until after December 15, 2009. Sandboxes 85-115 are reserved until then for use by the Biochemistry 451 class at Capital University taught by Prof. Jens Hemmingsen (jhemming@capital.edu).</td></tr>

This is '''myoglobin'''.

{{STRUCTURE_1a6m | PDB=1a6m | SCENE=Sandbox_85/Myoglobin_overview/3 }}
<scene name='Sandbox_85/Myoglobin_overview/3'>Original View</scene> 
<scene name='Sandbox_85/Secondary_structure/2'>Secondary Structure</scene> 
<scene name='Sandbox_85/Heme_closeup/1'>Heme closeup</scene> 
<scene name='Sandbox_85/Heme_closeup/2'>Iron ligands</scene> 
<scene name='Sandbox_85/Helixes/1'>Pink Helixes</scene> 
<scene name='Sandbox_85/Heme_zoomed/1'>Heme Only</scene> 
<scene name='Sandbox_85/Plx_4032/1'>JD needs this</scene>
<scene name='3og7/Superposition/5'>Overall superposition of LepA and EF-G.</scene> Note that the individual domains of '''LepA''' and '''EF-G''', such as III V, superimpose much better when done separately (shown in [http://www.pnas.org/content/105/12/4673/F2.expansion.html figure 2] of [http://www.pnas.org/content/105/12/4673.long the paper] describing the structure).

<applet load='1a6m' size='500' color='white' frame='true' align='right' caption='testcaption' />

Sandbox 85

2010-10-05T02:10:25Z

J.D. Woodruff:

<table style="background-color:#ffffc0" cellpadding="8" width="95%" border="0"><tr><td>Please do NOT make changes to this Sandbox until after December 15, 2009. Sandboxes 85-115 are reserved until then for use by the Biochemistry 451 class at Capital University taught by Prof. Jens Hemmingsen (jhemming@capital.edu).</td></tr>

This is '''myoglobin'''.

{{STRUCTURE_1a6m | PDB=1a6m | SCENE=Sandbox_85/Myoglobin_overview/3 }}
<scene name='Sandbox_85/Myoglobin_overview/3'>Original View</scene> 
<scene name='Sandbox_85/Secondary_structure/2'>Secondary Structure</scene> 
<scene name='Sandbox_85/Heme_closeup/1'>Heme closeup</scene> 
<scene name='Sandbox_85/Heme_closeup/2'>Iron ligands</scene> 
<scene name='Sandbox_85/Helixes/1'>Pink Helixes</scene> 
<scene name='Sandbox_85/Heme_zoomed/1'>Heme Only</scene> 
<scene name='Sandbox_85/Plx_4032/1'>JD needs this</scene>
<scene name='3cb4/Superposition/5'>Overall superposition of LepA and EF-G.</scene> Note that the individual domains of '''LepA''' and '''EF-G''', such as III V, superimpose much better when done separately (shown in [http://www.pnas.org/content/105/12/4673/F2.expansion.html figure 2] of [http://www.pnas.org/content/105/12/4673.long the paper] describing the structure).

<applet load='1a6m' size='500' color='white' frame='true' align='right' caption='testcaption' />

B-RAF with PLX4032

2010-09-30T17:34:10Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='600' color='white' frame='true' align='left' caption='testcaption' />
<applet load='1uwh' size='600' color='white' frame='true' align='right' caption='testcaption' />

B-RAF with PLX4032

2010-09-30T17:30:15Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='600' color='white' frame='true' align='left' caption='testcaption' />
<applet load='1uwh' size='600' color='white' frame='true' align='right' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T02:30:04Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T01:50:52Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T01:49:43Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>TextToBeDisplayed</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>TextToBeDisplayed</scene> 
<scene name='B-RAF_with_PLX4032/V600e_mutation/1'>V600E mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T01:42:50Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>TextToBeDisplayed</scene> 
<scene name='B-RAF_with_PLX4032/V600e_mutation/1'>V600E mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T01:37:16Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/V600e_mutation/1'>V600E mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T01:35:41Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/V600e_mutation/1'>V600E mutation</scene> 
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>TextToBeDisplayed</scene>
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T01:17:53Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/V600e_mutation/1'>V600E mutation</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T01:17:21Z

J.D. Woodruff:

==B-RAF with PLX4032==
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

Replace the PDB id (use lowercase!) after the STRUCTURE_ and after PDB= to load
and display another structure.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/V600e_mutation/1'>V600E mutation</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />

B-RAF with PLX4032

2010-09-29T01:14:05Z

J.D. Woodruff:

==B-RAF with PLX4032==
This is a placeholder text to help you get started in
placing a Jmol applet on your page. At any time, click
"Show Preview" at the bottom of this page to see how it goes.

Replace the PDB id (use lowercase!) after the STRUCTURE_ and after PDB= to load
and display another structure.

<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene> 
<scene name='B-RAF_with_PLX4032/V600e_mutation/1'>V600E mutation</scene> 
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene> 
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene>
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' />
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' />